Kevin Oeffinger, MD, is a family physician, Professor in the Department of Medicine, and a member of the Duke Cancer Institute (DCI). He is founding Director of the DCI Center for Onco-Primary Care, and Director of the DCI Supportive Care and Survivorship Center. He has a long-standing track record of NIH-supported research in cancer screening and survivorship and has served in a leadership capacity in various cancer-focused and primary care-focused national committees and organizations, including the American Society of Clinical Oncology, the American Cancer Society, and the American Academy of Family Physicians. He is currently an Associate Editor for the Journal of the National Cancer Institute.
The three-fold mission of the DCI Center for Onco-Primary Care are are to: (1) deliver evidence-based, patient-centered, personalized health care across the cancer continuum by enhancing the interface between cancer specialists and primary care clinicians; (2) conduct innovative research with cutting-edge technology that can be translated to the community setting; and (3) train and educate the next generation of clinicians and researchers to extend this mission.
Dr. Oeffinger's clinical expertise is managing survivors of pediatric and young adult cancer.
Education and Training
- Advanced Research Training, Epidemiology And Genetics, Radiation Epidemiology, National Cancer Institute, 1999 - 2000
- Family Medicine Academic Fellowship, Baylor College of Medicine, 1987 - 1988
- Family Medicine Internship and Residency, Baylor College of Medicine, 1984 - 1987
- M.D., University of Texas Health Science Center San Antonio, 1984
- Optimizing the Management and Outcomes for Cancer Survivors Transitioning to Follow-up Care
- Improving Symptom Management for Survivors of Young Adult Cancer
- Duke Creating ADRD Researchers for the Next Generation - Stimulating Access to Research in Residency Program (CARiNG-StARR)"
- Effectiveness trial of a head and neck cancer survivorship tool
- EMPOWER Study: Promoting BC Screening in Women Who Survived Childhood Cancer
- Technology-Enabled Activation of Skin Cancer Screening for Hematopoietic Cell Transplantation Survivors and their Primary Care Providers
- Improving Treatment of Cardiovascular Risk Factors in Childhood Cancer Survivors